News: Medicine

View:

2005

 

Found press releases

 

Micronic Receives Order for Omega6080 Laser Pattern Generator

TABY, Sweden – December 30, 2005 – Micronic Laser Systems AB (Stockholm Stock Exchange’s “Attract 40 list”: MICR), a leading global supplier of laser pattern generators for photomasks, said today it has received an order for an Omega6080 laser pattern generator. The Omega6080 is designed for high-volume production of semiconductor photomasks, typically meeting critical-layer requirements at the 250 nm technology...

IMPAC ANNOUNCES AUTOMATED SOLUTION UPDATE TO SUPPORT 2006 CMS ONCOLOGY DEMONSTRA...

PRESS RELEASE Mountain View, Calif., December 22, 2005 IMPAC Medical Systems, Inc., part of the Elekta Group and a leading provider of information technology solutions for oncology care, announced today its plans to release CMS 2006 Quality of Care – an updated product solution in IMPAC’s oncology electronic medical record (EMR) designed to support CMS’ (Center for Medicare & Medicaid Services) 2006 oncology...

ASTRAZENECA AND ATHEROGENICS ANNOUNCE LATE STAGE LICENSING AND COMMERCIALISATION...

AstraZeneca today announced that it has entered into a licensing deal with AtheroGenics, Inc. (Nasdaq: AGIX) for the global development and commercialisation of their anti-inflammatory cardiovascular product candidate, AGI-1067. AGI-1067 is an investigational oral drug for the treatment of atherosclerosis, the underlying disease process that leads to heart attacks and strokes and is currently in Phase III...

Orexo announces a licensing agreement for its pain product Rapinyl™ (OX 20) for ...

Orexo AB and ProStrakan Group plc today announced that they have entered into a licensing agreement under which ProStrakan as of January 2nd, 2006, receives exclusive rights to register and market Rapinyl™ (OX 20) – Orexo´s patented product for management of breakthrough cancer pain – on the European market.

In return for these rights, Orexo will receive an up-front license fee payment of 5 M EURO (approximately...

ELEKTA TO DELIVER LEKSELL GAMMA KNIFE® TO VIETNAM

PRESS RELEASE
Stockholm, December 12, 2005

Elekta has signed an agreement to deliver Leksell Gamma Knife® to Vietnam’s largest regional government hospital, Cho Ray Hospital, in Ho Chi Minh City.
Cho Ray Hospital is the largest regional government hospital in Vietnam with 1,800 beds. It acts as the central hospital, serving patients referred from southern and central Vietnam as well as Laos and Cambodia. Cho...

Interim report for the six-month period May 1 - October 31, 2005

• Order bookings rose 32 percent to SEK 1,997 M (1,515). The order backlog was on an all time high level of SEK 3,823 M. • Net sales increased 32 percent to SEK 1,940 M (1,466). • Operating profit amounted to SEK 153 M (179) and operating margins to 8 percent (12). On a rolling 12-month basis, operating margin was 9 percent. • Profit after taxes amounted to SEK 98 M (124). Earnings per share after dilution...

Karolinska selects Ortivus for cardiac care

Karolinska University hospital in Solna and Huddinge has placed a SEK 7.23 million order with Ortivus to supply its CoroNet system for monitoring of cardiac patients. The system will be delivered in the first quarter of 2006.

The order follows a successful launch of CoroNet under 2005 with tenders having already being won at several other hospitals in Sweden, including S:t Görans hospital in Stockholm, all cardiac...

ELEKTA RECEIVE ORDER FOR COMPLETE IMPAC IT SOLUTION THROUGHOUT GÉNÉRIDIS NETWORK...

PRESS RELEASE
Stockholm, December 8, 2005

With the fight against cancer now an issue of major national importance in France, Généridis, a subsidiary of Générale de Santé, the first coordinated network of private radiation oncology centers in the country, have elected to install a complete IMPAC IT solution from Elekta throughout their sites.
IMPAC’s Oncology Information System (OIS) will be introduced to...

ELEKTA ACQUIRES MEDICAL INTELLIGENCE

PRESS RELEASE
Stockholm, December 1, 2005

Elekta, world leader in advanced radiation therapy, comprehensive cancer management and non-invasive treatment of brain disorders, today announced the acquisition of Medical Intelligence Medizintechnik GmbH for a consideration of EUR 20 M in cash.
By acquiring Medical Intelligence Medizintechnik GmbH (MI), Elekta reinforces its leadership in stereotactic radiation...

Group executives buy warrants

Members of Meda’s new executive management team bought a total of 1,625,000 warrants in Meda. This team was formed after the Viatris acquisition. Each warrant entitles the right to subscribe for one new share in the company at SEK 150 per share – as per the extraordinary general meeting decision in October 2005. The subscription period runs from 27 February 2006 to 26 February 2008. Going forward, additional key...